Tuberous Sclerosis Complex (TSC) is a lifelong, multisystem genetic disorder characterized by benign tumors that can develop in the brain, skin, kidneys, heart, and lungs. Because TSC affects multiple organ systems, coordinated care across neurology, dermatology, nephrology, pulmonology, and behavioral health is essential.
Neurologic involvement is common: more than 80% of individuals with TSC develop seizure disorders. Many require long-term management beginning in infancy or early childhood, with seizure control becoming the most urgent and complex aspect of treatment. Pediatric patients managing refractory epilepsy or infantile spasms are particularly vulnerable to therapy interruptions, which can compromise clinical outcomes.
As treatment options evolve—including oral kinase inhibitors, mTOR-targeted therapies, and advanced antiseizure medications—the administrative demands on clinical teams increase. Many therapies involve REMS (Risk Evaluation and Mitigation Strategy) oversight, payer complexities, and detailed monitoring protocols. In this environment, continuity of care is not simply operational. It is clinical.
Specialty pharmacy plays an important role in protecting that continuity.
Emerging data from AMCP Nexus 2025 highlights that care fragmentation increases the likelihood of therapy interruption by approximately 35%. Such interruptions are associated with higher rates of clinical deterioration and unplanned healthcare utilization.
While these findings span multiple high-complexity disease states, the implications for TSC are clear: consistent therapeutic exposure is essential, as even brief gaps in medication—especially for seizure management—can compromise progress. For patients, particularly children, managing chronic neurologic conditions, uninterrupted therapy is foundational to long-term stability.
Total Care RX partners with prescribers to support patients on TSC-associated therapies, such as:
These therapies often require REMS oversight, complex prior authorization, financial assistance navigation, temperature-controlled shipping, and ongoing caregiver education. Ensuring consistent access requires more than dispensing medication—it depends on a proactive specialty pharmacy model focused on patient access to rare disease products and tailored support services.
In complex pediatric neurology, refill reliability is a leading indicator of care stability.
Within its pediatric neurology programs, Total Care RX reports 3.5 times higher refill rates compared to traditional pharmacy models. This reflects a structured adherence-and-follow-up approach that includes:
Higher refill continuity does more than reflect operational efficiency; it signals that therapy gaps are minimized and allows clinical teams to focus on disease management rather than troubleshooting access issues.
Several TSC-associated therapies require REMS oversight or enhanced monitoring. Specialty pharmacy coordination can alleviate administrative burden through:
This coordination helps maintain regulatory alignment, patient safety, and uninterrupted therapy.
“Children living with TSC require careful coordination and clinical vigilance as they are typically on multiple medications to treat different manifestations of TSC,” says Andrew Wroblewski, PharmD, Managing Director of Product and Compliance at Total Care RX. “Our responsibility extends beyond dispensing medication. We focus on ensuring families experience uninterrupted therapy, proactive support, and clear communication because in pediatric neurology, even short disruptions can have negative consequences.”
This philosophy reflects Total Care RX’s broader commitment to partnership, not just fulfillment.
TSC care is inherently multidisciplinary. When specialty pharmacy operates as an integrated clinical partner, it enables:
By combining proactive coordination, structured refill oversight, and personalized patient support, specialty pharmacies help reduce preventable gaps and support better outcomes for patients managing benign tumors and seizure disorders associated with TSC.
Continuity of care is a clinical safeguard in complex disease management. By partnering with a specialty pharmacy experienced in rare disease product patient access and comprehensive support services, prescribers can ensure patients with TSC receive consistent therapy, timely interventions, and the support needed to manage a lifelong condition.
Connect with our team to learn how we can support patients with TSC and enhance medication access and continuity of care. If you are experiencing disruptions in your refills, we can help restore seamless therapy management.